Shan Dong Kexing Bioproducts Co (SHSE:688136) NonCurrent Deferred Liabilities: ¥0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688136 Shan Dong Kexing Bioproducts Co Ltd SHSE:688136
46 GF Score
Price ¥17.68
GF Value ¥24.26
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shan Dong Kexing Bioproducts Co NonCurrent Deferred Liabilities?

Shan Dong Kexing Bioproducts Co SHSE:688136 +3.63% 46 NonCurrent Deferred Liabilities is ¥0 Mil as of Mar. 2026. GuruFocus rates SHSE:688136 with a GF Score™ of 46/100 and a GF Value™ of ¥24.26 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Shan Dong Kexing Bioproducts Co's non-current deferred liabilities for the quarter that ended in Mar. 2026 was ¥0 Mil.

Shan Dong Kexing Bioproducts Co NonCurrent Deferred Liabilities Related Terms

Shan Dong Kexing Bioproducts Co NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Shan Dong Kexing Bioproducts Co's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shan Dong Kexing Bioproducts Co NonCurrent Deferred Liabilities Chart

Shan Dong Kexing Bioproducts Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Shan Dong Kexing Bioproducts Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SHSE:688136
46GF Score
Shan Dong Kexing Bioproducts Co Ltd SHSE:688136
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of ¥0 Mil mean?
Shan Dong Kexing Bioproducts Co (SHSE:688136) has a NonCurrent Deferred Liabilities of ¥0 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Shan Dong Kexing Bioproducts Co and its competitors.
Is Shan Dong Kexing Bioproducts Co's NonCurrent Deferred Liabilities too high?
Shan Dong Kexing Bioproducts Co's current NonCurrent Deferred Liabilities is ¥0 Mil. Overall, Shan Dong Kexing Bioproducts Co has a GF Score™ of 46/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shan Dong Kexing Bioproducts Co's NonCurrent Deferred Liabilities compare to VRTX and REGN?
Shan Dong Kexing Bioproducts Co's NonCurrent Deferred Liabilities of ¥0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Biotechnology company?
A good NonCurrent Deferred Liabilities depends on the Biotechnology industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Shan Dong Kexing Bioproducts Co and its competitors. Shan Dong Kexing Bioproducts Co's current NonCurrent Deferred Liabilities is ¥0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shan Dong Kexing Bioproducts Co stock overvalued right now?
Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co (SHSE:688136) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥24.26, compared to a current price of ¥17.68 — trading 27.1% below its estimated fair value. The current NonCurrent Deferred Liabilities is ¥0 Mil. Shan Dong Kexing Bioproducts Co's overall GF Score™ is 46/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Shan Dong Kexing Bioproducts Co (SHSE:688136), the current NonCurrent Deferred Liabilities is ¥0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shan Dong Kexing Bioproducts Co (SHSE:688136) Overvalued in 2026?

Based on GuruFocus' analysis, Shan Dong Kexing Bioproducts Co stock appears to be undervalued. The current stock price of ¥17.68 is trading 27.1% below its estimated GF Value™ of ¥24.26. GuruFocus considers Shan Dong Kexing Bioproducts Co to be Modestly Undervalued.

Key valuation signals for SHSE:688136:

  • NonCurrent Deferred Liabilities: ¥0 Mil
  • GF Value™: ¥24.26 vs. price of ¥17.68 (27.1% below fair value)
  • GF Score™: 46/100 with 7 warning signs

No single metric tells the full story. See the SHSE:688136 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shan Dong Kexing Bioproducts Co Business Description

Address No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Shandong Province, Jinan, CHN, 250200
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
46GF Score

Get the complete analysis for SHSE:688136

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.68
Price
¥24.26
GF Value